iNKT cells
iNKT cells require TSC1 for terminal maturation and effector lineage fate decisions
15
Induction of antiinflammatory purinergic signaling in activated human iNKT cells
13
Original Article A critical role of CXCR6 in murine myocardial ischemia-reperfusion injury through activating IL-17a producing iNKT cells
8
Shared and distinct transcriptional programs underlie the hybrid nature of iNKT cells
30
Temporal differences in the dependency on Phosphoinositide dependent kinase 1 distinguish the development of V?14 iNKT cells, regulatory T cells and conventional T cells
23
Development of genetically engineered iNKT cells expressing TCRs specific for the M tuberculosis 38 kDa antigen
10
Spontaneous focal activation of invariant natural killer T (iNKT) cells in mouse liver and kidney
12
Deficiency of innate-like T lymphocytes in chronic obstructive pulmonary disease
10
Type I Interferons Triggered through the Toll-Like Receptor 3–TRIF Pathway Control Coxsackievirus A16 Infection in Young Mice
8
Intracellular Bacterial Infection and Invariant NKT Cells
10
PubMedCentral-PMC5289534.pdf
14
Natural killer T cells in adipose tissue prevent insulin resistance
13
Accumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia
10
Elevated expression of LAG 3, but not PD 1, is associated with impaired iNKT cytokine production during chronic HIV 1 infection and treatment
17
TIM-4 is expressed on invariant NKT cells but dispensable for their development and function
13
iNKT/CD1d-antitumor immunotherapy significantly increases the efficacy of therapeutic CpG/peptide-based cancer vaccine
12
TNF superfamily receptor OX40 triggers invariant NKT cell pyroptosis and liver injury
14
Cytotoxic lymphocytes in COPD airways: increased NK cells associated with disease, iNKT and NKT-like cells with current smoking
10
Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients
9
Novel thioglycoside analogs of α galactosylceramide stimulate cytotoxicity and preferential Th1 cytokine production by human invariant natural killer T cells
10